North American Zoonoses

被引:8
作者
Lieberman, Jay M. [1 ,2 ,3 ]
机构
[1] Quest Diagnost Nichols Inst, San Juan Capistrano, CA USA
[2] Focus Diagnost, Cypress, CA USA
[3] Univ Calif Irvine, Irvine, CA USA
来源
PEDIATRIC ANNALS | 2009年 / 38卷 / 04期
关键词
CAT-SCRATCH DISEASE; BARTONELLA-HENSELAE; ESCHERICHIA-COLI; MURINE TYPHUS; RISK-FACTORS; SHIGA-TOXIN; TULAREMIA; FEATURES; FEVER;
D O I
10.3928/00904481-20090401-09
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
A variety of infectious agents can be transmitted from animals to humans, either directly or indirectly. Unfortunately, the diagnosis of a zoonosis may not be considered at presentation, which can lead to a delay in initiating appropriate therapy, or is never made because the symptoms are non-specific and no exposure history is obtained. The keys to making a diagnosis are to recognize the clinical manifestations of the diseases (eg, fever of unknown origin, arthritis, rash, or lymphadenopathy), to obtain an exposure history, and to understand the local epidemiology. When a child presents with an unexplained febrile illness or infectious disease, clinicians should ask about potential exposures to animals, including pets, ingestion of unusual foods, such as raw or unpasteurized milk, and a travel history.
引用
收藏
页码:193 / 198
页数:6
相关论文
共 28 条
[1]  
Anonymous, 2005, Morbidity and Mortality Weekly Report, V54, P1277
[2]   Hepatosplenic cat-scratch disease in children: Selected clinical features and treatment [J].
Arisoy, ES ;
Correa, AG ;
Wagner, ML ;
Kaplan, SL .
CLINICAL INFECTIOUS DISEASES, 1999, 28 (04) :778-784
[3]  
Atkinson R., 2006, Morbidity and Mortality Weekly Report, V55, P1042
[4]   Prospective randomized double blind placebo-controlled evaluation of azithromycin for treatment of cat-scratch disease [J].
Bass, JW ;
Freitas, BC ;
Freitas, AD ;
Freitas, D ;
Sisler, CL ;
Chan, DS ;
Vincent, JM ;
Person, DA ;
Claybaugh, JR ;
Wittler, RR ;
Weisse, ME ;
Regnery, RL ;
Slater, LN .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1998, 17 (06) :447-452
[5]  
Bertram-Sosa L., 2006, Morbidity and Mortality Weekly Report, V55, P940
[6]  
Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P1224
[7]  
Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V53, P1198
[8]  
Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P181
[9]   BARTONELLA HENSELAE PREVALENCE IN DOMESTIC CATS IN CALIFORNIA - RISK-FACTORS AND ASSOCIATION BETWEEN BACTEREMIA AND ANTIBODY-TITERS [J].
CHOMEL, BB ;
ABBOTT, RC ;
KASTEN, RW ;
FLOYDHAWKINS, KA ;
KASS, PH ;
GLASER, CA ;
PEDERSEN, NC ;
KOEHLER, JE .
JOURNAL OF CLINICAL MICROBIOLOGY, 1995, 33 (09) :2445-2450
[10]   TULAREMIA - TREATMENT FAILURES WITH OUTPATIENT USE OF CEFTRIAXONE [J].
CROSS, JT ;
JACOBS, RF .
CLINICAL INFECTIOUS DISEASES, 1993, 17 (06) :976-980